Search by Drug Name or NDC

    NDC 45802-0129-32 Halobetasol Propionate 0.5 mg/g Details

    Halobetasol Propionate 0.5 mg/g

    Halobetasol Propionate is a TOPICAL CREAM in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Padagis Israel Pharmaceuticals Ltd. The primary component is HALOBETASOL PROPIONATE.

    Product Information

    NDC 45802-0129
    Product ID 45802-129_4f3d068f-2393-41c4-9d14-47106cd5c6a0
    Associated GPIs 90550073103710
    GCN Sequence Number 015605
    GCN Sequence Number Description halobetasol propionate CREAM (G) 0.05 % TOPICAL
    HIC3 Q5P
    HIC3 Description TOPICAL ANTI-INFLAMMATORY STEROIDAL
    GCN 31251
    HICL Sequence Number 006037
    HICL Sequence Number Description HALOBETASOL PROPIONATE
    Brand/Generic Generic
    Proprietary Name Halobetasol Propionate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Halobetasol Propionate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CREAM
    Route TOPICAL
    Active Ingredient Strength 0.5
    Active Ingredient Units mg/g
    Substance Name HALOBETASOL PROPIONATE
    Labeler Name Padagis Israel Pharmaceuticals Ltd
    Pharmaceutical Class Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA077123
    Listing Certified Through 2025-12-31

    Package

    NDC 45802-0129-32 (45802012932)

    NDC Package Code 45802-129-32
    Billing NDC 45802012932
    Package 1 TUBE in 1 CARTON (45802-129-32) / 50 g in 1 TUBE
    Marketing Start Date 2008-08-04
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.51359
    Pricing Unit GM
    Effective Date 2024-02-21
    NDC Description HALOBETASOL PROP 0.05% CREAM
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis